Sandra Orsulic, PhD

Sandra Orsulic, PhD is a Professor in the Departments of Obstetrics & Gynecology and Pathology & Laboratory Medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Dr. Orsulic was previously a Professor of Obstetrics and Gynecology at Cedars-Sinai Medical Center. Prior to moving to Los Angeles, she was an Assistant Molecular Pathologist at the Massachusetts General Hospital in Boston, where she also served as Assistant Professor of Pathology at Harvard Medical School.

Her research includes studying the mechanisms by which the microenvironment contributes to cancer initiation and metastatic progression, identifying molecular markers for early cancer detection and therapeutic targeting, and generating preclinical models for testing targeted therapies.

Dr. Orsulic is a member of the Ovarian Cancer Research Alliance Scientific Advisory Committee (USA) and the Ovarian Cancer Research Fund Scientific Advisory Committee (Australia). She also serves on several editorial boards and NIH review panels.

Dr. Orsulic’s research on ovarian cancer has been funded by the National Institutes of Health (NIH), Department of Defense (DoD), Department of Veterans Affairs (VA), American Cancer Society (ACS) and Ovarian Cancer Research Alliance (OCRA). Her studies have been published in peer-reviewed journals such as Nature, Cancer Cell, Science Advances, Proceedings of the National Academy of Sciences, USA (PNAS) and Cancer Research.